The role of microRNA-133 in cardiac hypertrophy uncovered.
作者信息
Abdellatif Maha
出版信息
Circ Res. 2010 Jan 8;106(1):16-8. doi: 10.1161/CIRCRESAHA.109.212183.
Abstract
摘要
相似文献
1
The role of microRNA-133 in cardiac hypertrophy uncovered.
Circ Res. 2010 Jan 8;106(1):16-8. doi: 10.1161/CIRCRESAHA.109.212183.
2
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.
Circ Res. 2010 Jan 8;106(1):166-75. doi: 10.1161/CIRCRESAHA.109.202176. Epub 2009 Nov 5.
3
Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase.
Proteomics Clin Appl. 2020 Jul;14(4):e2000017. doi: 10.1002/prca.202000017. Epub 2020 Jun 23.
4
Hyperoxia-induced hypertrophy and ion channel remodeling in left ventricle.
Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1651-61. doi: 10.1152/ajpheart.00474.2012. Epub 2013 Apr 12.
5
Cardiomyocytic FoxP3 Attenuates Expression of β Isoform of Myosin Heavy Chain During Cardiac Hypertrophy and Effects of Triptolide.
J Cell Physiol. 2025 Mar;240(3):e70026. doi: 10.1002/jcp.70026.
6
Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.
J Biol Chem. 2008 Sep 26;283(39):26484-9. doi: 10.1074/jbc.M803686200. Epub 2008 Jul 14.
7
MG53, A Novel Regulator of KChIP2 and I, Plays a Critical Role in Electrophysiological Remodeling in Cardiac Hypertrophy.
Circulation. 2019 Apr 30;139(18):2142-2156. doi: 10.1161/CIRCULATIONAHA.118.029413.
8
MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
Circ Res. 2013 Apr 26;112(9):1234-43. doi: 10.1161/CIRCRESAHA.112.300682. Epub 2013 Mar 22.
9
K(ATP) channel gain-of-function leads to increased myocardial L-type Ca(2+) current and contractility in Cantu syndrome.
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6773-8. doi: 10.1073/pnas.1606465113. Epub 2016 May 31.
10
Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Cardiovasc Res. 2021 May 25;117(6):1532-1545. doi: 10.1093/cvr/cvaa233.
引用本文的文献
1
Targeting miRNA with flavonoids: unlocking novel pathways in cardiovascular disease management.
Front Pharmacol. 2025 Mar 6;16:1532986. doi: 10.3389/fphar.2025.1532986. eCollection 2025.
2
Analysis of MicroRNA Cargo in Circulating Extracellular Vesicles from HIV-Infected Individuals with Pulmonary Hypertension.
Cells. 2024 May 21;13(11):886. doi: 10.3390/cells13110886.
3
miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis.
Noncoding RNA Res. 2023 Dec 20;9(1):253-261. doi: 10.1016/j.ncrna.2023.12.003. eCollection 2024 Mar.
4
Epigenetics and Gut Microbiota Crosstalk: A potential Factor in Pathogenesis of Cardiovascular Disorders.
Bioengineering (Basel). 2022 Dec 13;9(12):798. doi: 10.3390/bioengineering9120798.
5
Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Endocrine. 2022 Aug;77(2):380-391. doi: 10.1007/s12020-022-03103-x. Epub 2022 Jun 8.
6
The Role of microRNA-133 in Hemocyte Proliferation and Innate Immunity of .
Front Immunol. 2022 Jan 27;12:812717. doi: 10.3389/fimmu.2021.812717. eCollection 2021.
7
MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease?
Cells. 2021 Nov 30;10(12):3374. doi: 10.3390/cells10123374.
8
MicroRNAs in Acute ST Elevation Myocardial Infarction-A New Tool for Diagnosis and Prognosis: Therapeutic Implications.
Int J Mol Sci. 2021 Apr 30;22(9):4799. doi: 10.3390/ijms22094799.
9
The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac Remodelling.
Int J Mol Sci. 2021 Apr 30;22(9):4762. doi: 10.3390/ijms22094762.
10
Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.
J Cardiovasc Dev Dis. 2021 Feb 19;8(2):22. doi: 10.3390/jcdd8020022.
本文引用的文献
1
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.
Circ Res. 2010 Jan 8;106(1):166-75. doi: 10.1161/CIRCRESAHA.109.202176. Epub 2009 Nov 5.
2
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
Biochem Biophys Res Commun. 2009 Oct 23;388(3):483-9. doi: 10.1016/j.bbrc.2009.07.143. Epub 2009 Aug 3.
3
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.
Circ Res. 2009 Apr 10;104(7):879-86. doi: 10.1161/CIRCRESAHA.108.193102. Epub 2009 Mar 5.
4
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178. doi: 10.1161/CIRCRESAHA.108.182535. Epub 2008 Dec 18.
5
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.
Genes Dev. 2008 Dec 1;22(23):3242-54. doi: 10.1101/gad.1738708. Epub 2008 Nov 17.
6
A microRNA signature for a BMP2-induced osteoblast lineage commitment program.
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13906-11. doi: 10.1073/pnas.0804438105. Epub 2008 Sep 10.
7
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.
J Biol Chem. 2008 Jul 18;283(29):20045-52. doi: 10.1074/jbc.M801035200. Epub 2008 May 5.
8
MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.
Cell Stem Cell. 2008 Mar 6;2(3):219-29. doi: 10.1016/j.stem.2008.01.016.
9
Fgf-dependent depletion of microRNA-133 promotes appendage regeneration in zebrafish.
Genes Dev. 2008 Mar 15;22(6):728-33. doi: 10.1101/gad.1641808.
10
A MicroRNA feedback circuit in midbrain dopamine neurons.
Science. 2007 Aug 31;317(5842):1220-4. doi: 10.1126/science.1140481.
Zotero 插件